A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China
IH
1 other identifier
observational
10,000
1 country
1
Brief Summary
Infant hemangioma(IH) is the most common benign vascular tumor of infancy with the estimated incidence varies 1% to 12%.However, in China, the incidence of infant hemangioma and related epidemiological data remains unclear. So, the investigators designed the study for the following purposes: 1, to aware the incidence of infantile hemangioma and understand the related risk factorsin China; 2, to understand the clinical characteristics of infantile hemangioma and the risk factors for complications; 3, to investigate the level of knowledge, treatment options in infant hemangioma in Chinese doctors; 3, to improve the awareness of infantile hemangioma in parents and provide more advice for pregnancy counseling and eugenics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 29, 2017
CompletedFirst Posted
Study publicly available on registry
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedJune 2, 2017
June 1, 2017
1.8 years
May 29, 2017
June 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence rate of infantile hemangioma in China
Data collected by questionnaire of infantile hemangioma, filled by the investigators
about 1 years
Study Arms (1)
Infant hemangioma(IH)
Infant hemangioma(IH) is the most common benign vascular tumor of infancy with the estimated incidence varies 1% to 12%.However, in China, the incidence of infant hemangioma and related epidemiological data remains unclear. So, We designed the study to collect data about both epidemiology related risk ractors of infantile hemangioma in China.
Eligibility Criteria
All infants from the selected community
You may qualify if:
- Chinese
- The infants within 12 months of age
You may not qualify if:
- Those whoes guardian does not want his data to be collected in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhujiang Hospital
Guangzhou, Guangdong, 510515, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tangde Zhang, Doctor
Zhujiang Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 29, 2017
First Posted
June 1, 2017
Study Start
December 1, 2015
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
June 2, 2017
Record last verified: 2017-06